Musk's neuralink serves patient data from brain implants at Journal

Neuralink Corp., Elon Musk’s brain planting business, submitted a scientific article to a magazine describing the results of some of its patients, which would be the first peer-reviewed publication with human data. The newspaper was sent to the New England Journal of Medicine and described the first three patients implanted at the Neuralink device, including security data, according to Michael Lawton, CEO and president of the Barrow Neurological Institute, a neural clinical test site. Neuralink is one of several companies that develop brain-computer interfaces, enabling direct communication between the brain and electronic devices. The company raised more than $ 1 billion and has been valued at $ 9 billion in its most recent fundraising round, but it has yet to publish peer-reviewed human data. Outside scientists, these results can use to evaluate independently how well his devices work. Neuralink’s founder of celebrities has attracted an increasing attention and investment on the field and accelerates research and development at various businesses. Other businesses and academics have published widely in the field. Lawton shared these details in a conversation about the sidelines of a brain implant conference in New York, hosted by the Mount Sinai Health System. He did not want to provide more details on the newspaper. Neuralink did not respond to a request for comment. The company has previously announced that it has put its implant so far into 12 people. The president of the company, DJ SEO, said in September that the company hopes to put its device in a healthy person by 2030. So far, brain collections that patients use to control computers are only experimentally implanted in patients with serious medical needs. Neuralink has a vision to apply a link to almost anyone who has a possible need for it, “Lawton said on a panel moderated by Bloomberg News on Friday at the conference. He added that the company is a long way to do it with a healthy person. “They were very careful about focusing on sick patients with disability,” he said. The company intends to plant its chips in 20,000 people per year by 2031 and earns at least $ 1 billion in annual revenue. In addition to his device that helps people control computers, he also works on chips to restore vision, read speech from the brain and treat Parkinson. With the help of Jessica Nix. © 2025 Bloomberg MP This article was generated from an automatic news agency feed without edits to text.